{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00576",
      "entity_text" : "DPP4 inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The exact mechanism how DPP4 inhibitors augment insulin secretion and increase beta-cell mass in vitro and in vivo is still not fully understood, since not all these effects could be explained by elevated GLP-1 level or improved glycemic control associated with less glucotoxicity.",
  "reading_complete" : "2020-08-04T09:52:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:47:07Z",
  "trigger" : "augment",
  "evidence" : [ "DPP4 inhibitors augment insulin" ],
  "pmc_id" : "4515598",
  "score" : 0
}